v3.26.1
Unaudited Condensed Statements of Changes in Shareholders’ (Deficit) Equity - USD ($)
Class A
Ordinary Shares
Class B
Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2025 [1] $ 575 $ 24,425 $ (20,904) $ 4,096
Balance (in Shares) at Dec. 31, 2025 [1]   5,750,000      
Sale of 446,250 Private Placement Units $ 44 4,462,456 4,462,500
Sale of 446,250 Private Placement Units (in Shares) 446,250        
Fair value of Public Rights 3,967,500 3,967,500
Allocated value of transaction costs to Class A Ordinary Shares (249,948) (249,948)
Accretion for Class A Ordinary Shares to redemption amount (8,204,433) (5,985,994) (14,190,427)
Net income 152,021 152,021
Balance at Mar. 31, 2026 $ 44 $ 575 (5,854,877) (5,854,258)
Balance (in Shares) at Mar. 31, 2026 446,250 5,750,000      
Balance at Dec. 31, 2025 [1] $ 575 24,425 (20,904) 4,096
Balance (in Shares) at Dec. 31, 2025 [1]   5,750,000      
Net income         1,480,861
Balance at Jun. 30, 2026 $ 44 $ 575 (6,057,205) (6,056,586)
Balance (in Shares) at Jun. 30, 2026 446,250 5,750,000      
Balance at Mar. 31, 2026 $ 44 $ 575 (5,854,877) (5,854,258)
Balance (in Shares) at Mar. 31, 2026 446,250 5,750,000      
Accretion for Class A Ordinary Shares to redemption amount (1,531,168) (1,531,168)
Net income 1,328,840 1,328,840
Balance at Jun. 30, 2026 $ 44 $ 575 $ (6,057,205) $ (6,056,586)
Balance (in Shares) at Jun. 30, 2026 446,250 5,750,000      
[1] Includes 750,000 Class B Ordinary Shares subject to forfeiture if the Over-Allotment Option was not exercised in full or in part by the Underwriters (see Note 7). On March 12, 2026, the Underwriters exercised their Over-Allotment Option in full, which was settled as part of the closing of the Initial Public Offering. As a result of the full exercise of the Over-Allotment Option, 750,000 Founder Shares are no longer subject to forfeiture by the U.S. Sponsor and the Canada Sponsor (see Note 5).